NCT00460226已完成不适用
A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 238
- 主要终点
- Occurrence of non-serious rash during 12 weeks of treatment with lamotrigine in patients with bipolar I in Korea
研究概览
简要总结
This is multi-center, prospective, observational stud. This study is designed to evaluate the rate of non-serious rash in Korean bipolar I patients.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
lamotrigine
there is only one group.
干预措施: lamotrigine (Drug)
结局指标
主要结局
Occurrence of non-serious rash during 12 weeks of treatment with lamotrigine in patients with bipolar I in Korea
时间窗: 12 weeks
次要结局
- CGI-BP at Week 12 and occurrence of adverse events at Week 12(12 weeks)
研究者
相似试验
已完成
不适用
Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine SNasolabial FoldsMid Face Volume LossLip Volume EnhancementNCT06699147Jetema Co., Ltd.238
招募中
不适用
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaDiabetes Mellitus, Type 2NCT06647888Daewoong Pharmaceutical Co. LTD.12,000
已完成
不适用
A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japaneonatal jaundiceJPRN-UMIN000021057Kobe University6,000
已完成
不适用
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisRheumatoid ArthritisNCT00267852Wyeth is now a wholly owned subsidiary of Pfizer152
进行中（未招募）
不适用
To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes MellitusDiabetes Mellitus, Type 2NCT05926414Daewoong Pharmaceutical Co. LTD.15,000